Ensysce Biosciences, Inc. (ENSC) › Total AssetsEnsysce Biosciences, Inc. (ENSC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $202.43M2018: $204.83M2019: $196.51M2020: $351.8K2021: $16.42M2022: $5.89M2023: $2.71M2024: $5.60M2025: $7.45M$7.45M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$7.45M+33.1%2024$5.60M+106.7%2023$2.71M-54.0%2022$5.89M-64.2%2021$16.42M+4566.6%2020$351.8K-99.8%2019$196.51M-4.1%2018$204.83M+1.2%2017$202.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share